Health services research in cancer

Josep Maria Borras Andres

PRINCIPAL INVESTIGATORS
  • Ramón Clèries Soler
  • Maria Julieta Corral Garcia
  • Rebeca Font Marimon
  • Paula Alicia Judith Manchon Walsh
  • Pilar Mur Molina
  • Joan Prades Pérez
  • Josepa Ribes Puig
CLINICAL RESEARCHERS
  • Maite Antonio Rebollo
  • Josep Maria Escriba Jordana
  • Josep Alfons Espinas Piñol
  • Társila Ferro García
PREDOCTORAL RESEARCHERS
  • Maria Atares Lopez
  • Maria Olivia Cabrera Godoy
SCIENTIFIC SUPPORT
  • Andreu Albiach De Miguel
  • Laura Esteban Etchamendi
  • Jordi Galvez Escañuela
  • Laura Guarga Sole
  • Nuria Mila Diaz
  • Laura Pareja Fernandez
  • Laura Roca Bielva
  • Xavier Sanz Ayllon
  • Judit Solà Munmany
MANAGEMENT SUPPORT
  • Meritxell Nomen Artal
  • Carme Prades Perez
Cancer
EPIBELL

Scientific production

16

PAPERS

Average IF: 4,08

7

LED PAPERS

Average IF: 3,90

3 PUBLICATIONS IN FIRST DECILE

10 PUBLICATIONS IN FIRST QUARTILE

16 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Cabrera,MO;Ten Haaf,K;Borràs,JM;Font,R;Solà,J;Hubert,J;Ballesteros,M et al, Impact of lung cancer screening eligibility criteria on participants’ characteristics and healthcare resources., Int J Cancer, 2025;doi:10.1002/ijc.70263
  • Matallana,C;Manchon Walsh,P;Espin,E;Pascual,M;Biondo,S;Jimenez Toscano,M;Borràs,JM et al, Organ/space surgical site infection and long-term outcomes of rectal cancer surgery: retrospective population-based cohort study, BJS Open, 2025;9(3):doi:10.1093/bjsopen/zraf052
  • Vandemaele,M;Lewison,G;Martinussen,H;Borras,JM;Leech,M;Aznar,M;Blanchard,P et al, Outcomes and level of evidence in radiation therapy research and different categories of radiotherapy innovations: an ESTRO-VBRO bibliometrics analysis of the literature, Radiother Oncol, 2025;213111165-111165, doi:10.1016/j.radonc.2025.111165
  • Mur,P;Pozuelo,A;Tabernero,J;Albanell,J;Bellosillo,B;Bosch,F;Briones,J et al, Implementation of the precision oncology program in catalonia’s public health system: results, lessons learned, and future prospects., Clin Transl Oncol, 2025;doi:10.1007/s12094-025-04022-9
  • Rodriguez Ortega,A;Ferro,T;Ochoa Arnedo,C;Campos,G;Valverde,Y;Medina,JC;Borras,JM, The Evaluation of a Nursing Care Model for Breast Cancer: What Are Women’s Priorities?, J Nurs Manag, 2025;2025(1):8653274-8653274, doi:10.1155/jonm/8653274

Research highlights

PROJECTS

1 Granted competitive project
8 Ongoing competitive projects

PUBLISHED WORKS

1 Clinical guideline
1 Thes1s

NETWORKS

AGAUR SGR GRC

Selected projects

  • 848294. 4-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening. COMISSIÓ EUROPEA. Budget: 526.575€. 2020-2025. PI: JOSEP ALFONS ESPINAS PIÑOL.
  • 948973. IMA-cRCT: Effectiveness and cost-effectiveness of the Initial Medication Adherence Intervention: cluster randomized controlled trial and economic model. COMISSIÓ EUROPEA. Budget: 112.631€. 2025-2026. PI: MARIA RUBIO VALERA.
  • 1ZQC8H8RT. Recerca en serveis sanitaris en càncer (RSSC) – 2021 SGR. AGENCIA GESTIO D’AJUTS UNIV. I RECERCA. Budget: 40.000€. 2022-2025. PI: JOSEP MARIA BORRÀS ANDRÉS.
  • PI21/00687. Evaluación de una estrategia de intervención para la mejora de la adherencia a la terapia endocrina en mujeres con cáncer de mama basada en datos del sistema sanitario en Cataluña. Instituto de Salud Carlos III (ISCIII). Budget: 99.220€. 2022-2026. PI: JOSEP MARIA BORRÀS ANDRÉS.
  • 101136953. DEFINITIVE: Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer (101136953). COMISSIÓ EUROPEA. Budget: 126.708,75€. 2023-2028. PI: JOSEP MARIA BORRÀS ANDRÉS.